Yevgeniy Freyman

535 total citations
12 papers, 400 citations indexed

About

Yevgeniy Freyman is a scholar working on Molecular Biology, Infectious Diseases and Neurology. According to data from OpenAlex, Yevgeniy Freyman has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Neurology. Recurrent topics in Yevgeniy Freyman's work include Prion Diseases and Protein Misfolding (8 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Yevgeniy Freyman is often cited by papers focused on Prion Diseases and Protein Misfolding (8 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Yevgeniy Freyman collaborates with scholars based in United States, Australia and Germany. Yevgeniy Freyman's co-authors include Stephen J. DeArmond, Pierre Lessard, Stanley B. Prusiner, Jiri Safar, Gültekin Tamgüney, Camille Deering, Stanley B. Prusiner, Kurt Giles, Amanda L. Woerman and Steven H. Olson and has published in prestigious journals such as Cancer Research, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Yevgeniy Freyman

12 papers receiving 391 citations

Peers

Countries citing papers authored by Yevgeniy Freyman

Since Specialization

Citations

This map shows the geographic impact of Yevgeniy Freyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yevgeniy Freyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yevgeniy Freyman more than expected).

Fields of papers citing papers by Yevgeniy Freyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yevgeniy Freyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yevgeniy Freyman. The network helps show where Yevgeniy Freyman may publish in the future.

Co-authorship network of co-authors of Yevgeniy Freyman

This figure shows the co-authorship network connecting the top 25 collaborators of Yevgeniy Freyman. A scholar is included among the top collaborators of Yevgeniy Freyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yevgeniy Freyman. Yevgeniy Freyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	216 (PB204): The mechanistic basis of both deep and durable antitumor activity by combinatorial inhibition of MAT2A and PRMT5 in MTAP-deleted tumors 2024 ·European Journal of Cancer ·Damien Garbett, Arjun A. Rao, Manfréd M. Fischer, Brian Belmontes, (unknown), M. Appel, Zishui Fang, Kwong Wai Choy, Scott R. Tyler, Jeffrey A. Vivian, Yevgeniy Freyman, (unknown), (unknown), Anurag S. Rathore, Chun-Chun Li, (unknown), Paul E. Hughes, Peter Teriete, Michael A. White, Brett A. Neilan	1
2	Abstract 1637: MAT2A inhibition in MTAP-/- tumors confers mechanistic vulnerabilities to multiple clinically actionable synthetic lethal drug combinations 2023 ·Cancer Research ·(unknown), Jenny Laraio, (unknown), Hoang Tran, Marcus Fischer, Yevgeniy Freyman, Geeta Sharma, (unknown), Stephen Federowicz, Divya Pankajakshan, Brett A. Neilan, (unknown), Anthony Mazurek, Mark R. Lackner, Michael S. White, Zineb Mounir	2
3	Abstract 1644: Dual inhibition of MAT2A and PRMT5 delivers synergistic anti-tumor responses in preclinical models of MTAP-deleted cancer 2023 ·Cancer Research ·Marcus Fischer, (unknown), Brian Belmontes, (unknown), Yevgeniy Freyman, (unknown), (unknown), (unknown), (unknown), (unknown), Zineb Mounir, Mark R. Lackner, Paul E. Hughes, (unknown), Brett A. Neilan	4
4	Abstract 1278: MAT2A inhibitor, IDE397, displays broad anti-tumor activity across a panel of MTAP-deleted patient-derived xenografts 2021 ·Cancer Research ·Marcus Fischer, Neil E. Bhola, (unknown), Yevgeniy Freyman, Bing Yao, Zineb Mounir, Mark R. Lackner, Brett A. Neilan	6
5	MSA prions exhibit remarkable stability and resistance to inactivation 2017 ·Acta Neuropathologica ·Amanda L. Woerman, Sabeen A. Kazmi, Smita S. Patel, Yevgeniy Freyman, Abby Oehler, Atsushi Aoyagi, Daniel A. Mordes, Glenda M. Halliday, Lefkos Middleton, Steve Gentleman, Steven H. Olson, Stanley B. Prusiner	73
6	Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines 2017 ·JAMA Neurology ·Amanda L. Woerman, Smita S. Patel, Sabeen A. Kazmi, Abby Oehler, Yevgeniy Freyman, (unknown), Robert J. Cotter, Julian A. Castaneda, Steven H. Olson, Stanley B. Prusiner	30
7	Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells 2014 ·Bioorganic & Medicinal Chemistry ·B. Michael Silber, Joel R. Gever, (unknown), Zhe Li, Adam R. Renslo, Kartika Widjaja, (unknown), Kurt Giles, Yevgeniy Freyman, (unknown), John J. Irwin, Matthew P. Jacobson, Stanley B. Prusiner	19
8	Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice 2013 ·Pharmaceutical Research ·B. Michael Silber, (unknown), (unknown), Alejandra Gallardo‐Godoy, Adam R. Renslo, Deepak Dalvie, Kurt Giles, Yevgeniy Freyman, (unknown), Joel R. Gever, Zhe Li, Matthew P. Jacobson, Yong Huang, Leslie Z. Benet, Stanley B. Prusiner	26
9	Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice 2012 ·Molecular Therapy — Nucleic Acids ·(unknown), Gene Hung, (unknown), Kurt Giles, Chris Black, Sue Freier, Frank Bennett, Stephen J. DeArmond, Yevgeniy Freyman, Pierre Lessard, Sina Ghaemmaghami, Stanley B. Prusiner	36
10	Transmission and Detection of Prions in Feces 2008 ·The Journal of Infectious Diseases ·Jiri Safar, Pierre Lessard, Gültekin Tamgüney, Yevgeniy Freyman, Camille Deering, (unknown), Stephen J. DeArmond, Stanley B. Prusiner	114
11	Inactivation of Prions by Acidic Sodium Dodecyl Sulfate 2005 ·Journal of Virology ·David Peretz, Surachai Supattapone, Kurt Giles, Julie Vergara, Yevgeniy Freyman, Pierre Lessard, Jiri Safar, David V. Glidden, Charles E. McCulloch, (unknown), Michael Scott, Stephen J. DeArmond, Stanley B. Prusiner	88
12	P3-378 Evaluation of the efficacy of quinacrine in animal models of prion disease 2004 ·Neurobiology of Aging ·Chongsuk Ryou, Pierre Lessard, Yevgeniy Freyman, Barnaby C. H. May, (unknown), Michael A. Baldwin, (unknown), Bruce Miller, Michael D. Geschwind, Fred Cohen, Stephen J. DeArmond, Stanley B. Prusiner, Giuseppe Legname	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact